Sign In
Buy FRX
$12.00
+0 (+0%)
At Close: Dec 08, 2021
Fennec Announces Results of Annual Meeting
04:30pm, Wednesday, 10'th Jun 2026
RESEARCH TRIANGLE PARK, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
06:01pm, Thursday, 21'st May 2026
~ Growing Independent Research Efforts are Expanding Evidence Base Around How PEDMARK ® (sodium thiosulfate injection) May Benefit Broader and More Diverse Patient Populations ~
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Monday, 18'th May 2026
RESEARCH TRIANGLE PARK, N.C., May 18, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announ
Fennec Pharmaceuticals Inc. (FENC) Q1 2026 Earnings Call Transcript
12:20pm, Thursday, 14'th May 2026
Fennec Pharmaceuticals Inc. (FENC) Q1 2026 Earnings Call Transcript
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
06:30am, Thursday, 14'th May 2026
~ Achieved First Quarter 2026 Total Net Revenues of $15.1 Million, Up 73% Year Over Year ~ ~ Field Sales Expansion Showing Early Signs of Positive Results with Record PEDMARK ® Demand in April 2026 ~
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026
06:36am, Thursday, 07'th May 2026
RESEARCH TRIANGLE PARK, N.C., May 07, 2026 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Compa
Fennec Pharmaceuticals Inc. (FENC) Q4 2025 Earnings Call Transcript
12:24pm, Tuesday, 24'th Mar 2026
Fennec Pharmaceuticals Inc. (FENC) Q4 2025 Earnings Call Transcript
Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below Fifty Day Moving Average – Here’s What Happened
04:18am, Wednesday, 11'th Feb 2026
Fennec Pharmaceuticals Inc. (TSE: FRX - Get Free Report) shares passed below its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of C$10.50 and traded as low as
Southpoint Capital Advisors Lp Sells 160,100 Shares of Fennec Pharmaceuticals (TSE:FRX) Stock
04:06am, Monday, 15'th Dec 2025
Fennec Pharmaceuticals Inc. (TSE: FRX - Get Free Report) insider Southpoint Capital Advisors Lp sold 160,100 shares of Fennec Pharmaceuticals stock in a transaction dated Friday, November 14th. The st
Fennec Pharmaceuticals Inc. (FENC) Q2 2025 Earnings Call Transcript
03:34pm, Tuesday, 19'th Aug 2025
Fennec Pharmaceuticals Inc. (NASDAQ:FENC ) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Company Participants Jeffrey S. Hackman - CEO & Director Robert C.
Fennec: Pedmark Approval Can Help Minimize Chemo-Induced Hearing Loss In Pediatric Cancer Patients
03:52am, Monday, 24'th Oct 2022
After two CRLs, PEDMARK has finally been approved for preventing chemo-induced hearing loss in pediatric cancer patients. In addition to being both safe and effective, PEDMARK has not shown itself to
Buying Fennec Pharma Ahead Of September PDUFA For Pedmark
11:37pm, Monday, 22'nd Aug 2022
PDUFA for Pedmark (sodium thiosulfate) in treating platinum chemotherapy-induced cytotoxicity (ear toxicity) in children is scheduled on September 23. The company resolved the issues raised in the sec
Founders of Flash Reflex Training Method Launch BlazePod
06:44pm, Saturday, 30'th Jul 2022
SAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) — BlazePod, founders of the revolutionary Flash Reflex (FRX) training method designed to improve reaction time and performance through unique cognitive and
Beachbody, Myx Fitness Going Public Via SPAC Merger
05:02pm, Monday, 28'th Jun 2021
The Beachbody Company Group is merging with connected fitness company Myx Fitness Holdings to go public via a collaboration with the special-purpose acquisition company (SPAC) Forest Road Acquisition
NEW YORK & SANTA MONICA, Calif.--(BUSINESS WIRE)--Forest Road Acquisition Corp. (NYSE:FRX) (“Forest Road”) today announced that its stockholders have voted to approve the proposed three-way busine
